Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide.
Minerva Urol Nephrol
; 73(6): 863-865, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-35144373
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms, Castration-Resistant
/
Neutrophils
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
Minerva Urol Nephrol
Year:
2021
Document type:
Article